The company have demonstrably boosted the course of a new treatment for ATTR-CM, employing Attruby. Initial clinical information indicates potential benefits for individuals affected from the serious condition. The emphasis represents the company’s focus to treating critical medical requirements in this cardiology space. Attruby: BridgeBio's Nov